Drug Topics

JUNE 6, 2023

With the rise of prescription digital therapeutics, pharmacists will need to prepare to manage the new paradigms of care.

566

566

IDStewardship

JUNE 6, 2023

In this article, ChatGPT provides witty insights into the cross-roads of artificial intelligence and infectious diseases. Interview with: ChatGPT by OpenAI Interview by: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article Posted 7 June 2023 With the exception of the questions in bold, this entire text was written by ChatGPT. The only thing removed from the questions is the instruction “in a witty way” and a character limit was used in each of the questions.

Immunization 246

Immunization 246

Drug Topics

JUNE 6, 2023

A research article outlines the future of artificial intelligence in health care.

469

469

Fierce Healthcare

JUNE 6, 2023

Advancements around large language models and generative AI in healthcare are ramping up quickly and it's challenging to keep up with the evolving news. | Carbon Health debuted hands-free charting — an AI-enabled notes assistant — in its proprietary EHR across each of its clinics and providers while Tempus rolled out an AI-enabled clinical assistant for oncologists.

140

140

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

JUNE 6, 2023

According to a spokesperson, the company is prepared to take the lawsuit to the Supreme Court.

469

469

Fierce Healthcare

JUNE 6, 2023

Mayo Clinic is collaborating with Google Cloud to supercharge search tools with generative AI. | Mayo Clinic is collaborating with Google Cloud to supercharge search tools with generative AI. The health system aims to use the buzzy new technology to make it easier for doctors to get access to relevant medical notes, research papers or clinical guidelines.

Mayo Clinic 135

Mayo Clinic 135

Pharmacy Times

JUNE 6, 2023

Trial results support 5.4 mg/kg of trastuzumab deruxtecan as the optimal dose in individuals with HER2+ metastatic colorectal cancer.

130

130

Drug Topics

JUNE 6, 2023

Overall survival rates for various cancers differed by race.

247

247

IDStewardship

JUNE 6, 2023

In this article, ChatGPT weighs in on how pharmacists can use artificial intelligence. Interview with: ChatGPT by OpenAI Interview by: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article Posted 7 June 2023 With the exception of the questions in bold, this entire text was written by ChatGPT. Welcome, fellow curious minds, to a captivating interview that promises to open doors to a world where artificial intelligence (AI) and the pharmaceutical profession unite in a delightful dance.

Patient Care 130

Patient Care Prescription Filling Hospitals Medication Dispensing 130

Drug Topics

JUNE 6, 2023

Merck sues the federal government, the FDA will allow cancer drug imports from China, and a drug from GSK shows promise for endometrial cancer treatment.

FDA 247

FDA 247

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

JUNE 6, 2023

For young life scientists hoping to land a prestigious faculty job in academia, postdoctoral research is practically a requirement. But it’s not a path equally open to everyone. Freshly minted life science Ph.D. graduates who have started families or have big loans, or are Black or female, say they plan to pursue postdoc positions at lower rates than their peers, according to a STAT analysis that includes previously unreported data from the National Center for Science and Engineering Stat

129

129

Drug Topics

JUNE 6, 2023

Knowledge gaps exist around the timing of pneumonitis onset in patients treated with checkpoint inhibitors.

247

247

Fierce Healthcare

JUNE 6, 2023

Despite physician and advanced practice provider productivity continuing its post-pandemic recovery, compensation gains are being outstripped by the most severe inflationary growth in decades, acco | Despite physician and advanced practice provider productivity continuing its post-pandemic recovery, compensation gains are being outstripped by the most severe inflationary growth in decades, according to a new report.

128

128

Pharmacy Times

JUNE 6, 2023

Recent debates have surrounded whether cognitive deficits, specifically in middle-aged patients, may be driven by cardiovascular and metabolic comorbidities instead of distinct obstructive sleep apnea processes.

123

123

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

pharmaphorum

JUNE 6, 2023

UK plans $40m pilot of obesity drug Wegovy in primary care Phil.

117

117

Pharmacy Times

JUNE 6, 2023

Findings highlight the potential efficacy of combining 2 novel bispecific therapies, teclistamab-cqyv and talquetamab, which target distinct antigens on myeloma cells.

122

122

STAT

JUNE 6, 2023

Now that the Covid-19 public health emergency has ended, it’s awfully tempting to put the pandemic firmly behind us. But now is the time to look at what we have learned so that our public health communication can be more clear, consistent, and effective from now on. One thing that we haven’t talked about enough is the victories.

Communication 117

Communication 117

Pharmacy Times

JUNE 6, 2023

The proportion of participants with cytomegalovirus disease was 10% with letermovir and 12% with valganciclovir.

FDA 122

FDA 122

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Fierce Healthcare

JUNE 6, 2023

A federal appeals court held a brief hearing Tuesday afternoon to hear from attorneys on both sides as it decides whether to lift a nationwide freeze on a lower court's ruling that struck down prev | A federal appeals court held a brief hearing Tuesday afternoon to hear from attorneys on both sides as it decides whether to lift a nationwide freeze on a lower court's ruling that struck down preventive care protections in the Affordable Care Act.

117

117

Pharmacy Times

JUNE 6, 2023

Until this study, adjuvant immunotherapy was standard of care for stage 3B melanoma but not stage 2, which has relatively similar survival rates and risk of recurrence.

115

115

STAT

JUNE 6, 2023

BOSTON — As Biogen’s new CEO Chris Viehbacher pores over Biogen’s books and scouts out M&A deals, he may have one advantage his predecessor didn’t: a good relationship with his board of directors. Investors have expressed hope over the last several years that Biogen would make more acquisition deals, but it’s been a point of contention within the company.

112

112

Pharmaceutical Technology

JUNE 6, 2023

Alkeus Pharmaceuticals has raised $150m in Series B financing to support the registration and launch of gildeuretinol (ALK-001) to treat Stargardt disease, a genetic cause of blindness in children and young adults. Led by Bain Capital Life Sciences, the financing round has also seen participation from Sofinnova Investments, TCGX and Wellington Management.

111

111

STAT

JUNE 6, 2023

WASHINGTON — Medicare has chosen a Center for Medicare and Medicaid Innovation official to temporarily lead its implementation of Democrats’ drug pricing law, a document obtained by STAT shows. The agency, which told Congress it intends to hire 95 full-time staff to implement drug pricing policies, has slowly staffed up over the past 10 months.

Documentation 109

Documentation 109

pharmaphorum

JUNE 6, 2023

Eisai is latest pharma to suffer ransomware attack Phil.

105

105

STAT

JUNE 6, 2023

CHICAGO — A medical device made by Novocure that creates electric fields in the lungs via wearable skin patches extended the survival of patients with lung cancer in a clinical trial, researchers reported Tuesday. The findings could lead to a new approval for the device, called Optune, beyond its current marketing clearance to treat a type of brain cancer.

Chemotherapy 106

Chemotherapy Immunization 106

Drug Store News

JUNE 6, 2023

The Refillable Mosquito Repellent Candle features a nature-stoneware vessel in Cloud White, Stone Gray or Forest Green.

104

104

STAT

JUNE 6, 2023

There’s nothing better than a beautiful spring day after a long, cold winter. But there’s nothing worse than having that day ruined by the sneezing, sniffling, and itching that come with seasonal allergies. Scientists don’t actually completely understand why we get seasonal allergies. The best estimation is that they’re an immune response to toxins in the natural environment that pollen also happens to trigger.

Immunization 102

Immunization 102

Fierce Healthcare

JUNE 6, 2023

High-profile legislation restricting gender transition care recently enacted in Florida was halted this week by a federal judge concerned of immediate harm to patients and seemingly unconvinced tha | The district court judge's scathing order characterized restrictions on gender transition care as political and a likely violation of the Fourteenth Amendment's Equal Protection Clause.

98

98

STAT

JUNE 6, 2023

After finding a “cascade of failures” at a manufacturing plant run by a key chemotherapy supplier, the Food and Drug Administration will not allow the company to resume distribution in the U.S. beyond some   cancer medicines that are in short supply. The agency issued the import alert last week to Intas Pharmaceuticals, which is based in India, after its inspectors found a litany of quality-control problems that were detailed in a 36-page inspection report in December.

Chemotherapy 102

Chemotherapy FDA Documentation 102

European Pharmaceutical Review

JUNE 6, 2023

Manufacturing any new type of product requires a degree of process reinvention, but the unique demands of advanced therapies have presented challenges not seen in biopharmaceuticals since the early days of monoclonal antibodies. While the rapid growth of the field is pushing many players toward new efficiency, the industry remains quite a distance away from standardisation.

98

98

STAT

JUNE 6, 2023

WASHINGTON — More than 230 people have retired from the Food and Drug Administration since Oct. 1, Chief of Staff Julie Tierney said Monday. It’s part of a bigger wave of exits: In total, 634 employees have left the agency, which has a staff of about 18,000 people. There are about 2,000 vacancies at the FDA, which is a normal level at an agency that has for a long time struggled to hire and keep employees who can make bigger salaries in the private sector.

FDA 102

FDA 102

Drug Store News

JUNE 6, 2023

Ghost announced the return of its Bubblicious Strawberry Splash in Ghost Energy and Ghost Legend All Out energy drinks.

98

98

STAT

JUNE 6, 2023

BOSTON — While most panel discussions at the Biotechnology Innovation Organization’s international convention tend to be heavy on jargon and light on urgency, a conversation on Tuesday about the growing threat foreign influences pose to the industry’s trade secrets could not have been more direct. “It’s really easy to wake up one morning and realize that you might actually be an industrial spy for a foreign government,” said Allen Phelps, CEO of IPTalons

102

102